Scarica l'app Stockscreener
129.40
1.24%
-1.62
Dopo l'orario di chiusura:
129.41
0.010
+0.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Abbott Laboratories Borsa (ABT) Ultime notizie
Structural Heart Devices Market Set to Expand and Reach ~USD 25 Billion by 2032 Amid Rising Demand for Minimally Invasive Solutions | DelveInsight - GlobeNewswire Inc.
Saudi Arabia Blood Glucose Device Market Trends and Company - GlobeNewswire
Saudi Arabia Blood Glucose Device Market Trends and Company Analysis Report 2025-2033 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, and Novo Nordisk - Yahoo Finance
Chris Blumas' Past Picks: Brookfield Corp, Abbott Labs & Great-West Lifeco - BNN Bloomberg
United States Epilepsy Drugs Market Trends and Company - GlobeNewswire
United States Epilepsy Drugs Market Trends and Company Analysis Report 2025-2033 Featuring Eisai, UCB, H. Lundbeck, GW Pharmaceuticals, Abbott, Alkem Laboratories, Bausch Health, GSK - Yahoo Finance
US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche - Yahoo Finance
Abbott India's profit climbs on healthy pharmaceutical demand - Yahoo News Singapore
Top Abbott Executive Makes Significant Stock Sale! - TipRanks
Abbott Shakes Suit Over Meta, Google Data Sharing For Now - Law360
Abbott Laboratories poised to end in red after six-session rally - MSN
Abbott Labs Beats Class Action Over Meta, Google Info Sharing - Bloomberg Law News
Abbott Laboratories shows growth in core products amid market shifts - Yahoo Finance
Are Wall Street Analysts Predicting Abbott Laboratories Stock Will Climb Or Sink? - Barchart.com
Abbott Laboratories maintains steady performance amid market shifts - Express Healthcare
Precision Trading with Abbott Laboratories (ABT) Risk Zones - news.stocktradersdaily.com
Abbott's EPD Growth Beats Market Trends: Here's How to Play the Stock - MSN
How Abbott Laboratories (ABT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Abbott Laboratories Q2 Earnings: Dividends Don’t Lie (NYSE:ABT) - Seeking Alpha
Do New Glucose Monitoring Launches Signal Sustainable Profit Growth for Abbott (ABT)? - simplywall.st
Abbott Laboratories shares rise 1.11% intraday as Senseonics Holdings, Inc. reports Q2 revenue up 37%. - AInvest
Struggling US healthcare stocks endure rough 2025 but draw some bargain hunters - Reuters
Abbott launches next-gen MitraClip, TriClip G5 systems - MassDevice
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It - MSN
Abbott Laboratories' Earnings Raise Concerns Despite Strong Profit Numbers - AInvest
Abbott's Q2 Diabetes Care Sales Rise 19.6%: What's Backing It? - Yahoo Finance
Abbott Laboratories' (NYSE:ABT) Earnings Are Of Questionable Quality - Yahoo Finance
Arterial Stents Market Surge to 2035: Growth Driven by Abbott, Boston Scientific, BIOTRONIK & Biosensors - openPR.com
Medical Devices & SuppliesDiversified Stocks Q2 Highlights: Abbott Laboratories (NYSE:ABT) - Yahoo Finance
Abbott Laboratories (NYSE:ABT) Is a Favorite Amongst Institutional Investors Who Own 80% - 富途牛牛
What institutional investors are buying Abbott Laboratories stockOutstanding trading profits - Jammu Links News
What is the dividend policy of Abbott Laboratories stockFree Stock Chart Pattern Guide - Jammu Links News
Is it the right time to buy Abbott Laboratories stockTremendous wealth creation - Jammu Links News
How does Abbott Laboratories compare to its industry peersMaximize portfolio growth with professional advice - Jammu Links News
Abbott Laboratories Stock Analysis and ForecastCapitalize on momentum-driven opportunities - Jammu Links News
When is Abbott Laboratories stock expected to show significant growthConsistent high-performance stocks - jammulinksnews.com
UBS Shrugs Abbott Laboratories’ (ABT) Diagnostic Weakness Affirms ‘Buy’ Rating - MSN
Abbott Laboratories Second Quarter 2025 Earnings: EPS Beats Expectations - simplywall.st
Stock Analysis | Abbott Laboratories OutlookMixed Signals Amid Strong Fundamentals and Technical Uncertainty - AInvest
Similac NEC Lawsuit: 2025 Updates & List of Affected Formulas - Drugwatch.com
What makes Abbott Laboratories stock price move sharplyPotential Breakout Stock List Published This Week - metal.it
Abbott Laboratories Shares Drop 1.84 as Analysts Clash on Value Amid $850M Volume 155th in Market Activity - AInvest
How volatile is Abbott Laboratories stock compared to the marketMarket Forecast Signals For Fast Growth - Jammu Links News
Estimating The Fair Value Of Abbott Laboratories (NYSE:ABT) - Yahoo Finance
Abbott Laboratories 2025 Q2 Earnings Strong Performance as Net Income Climbs 36.6% - AInvest
Why Abbott Laboratories (ABT) Remains a Buy Despite Diagnostic Segment Weakness - AInvest
Biotechnology Market is evolving rapidly Through 2025 To 2032 | Abbott Laboratories, Amgen Inc., GlaxoSmithKline - openPR.com
Abbott Gains 1.31% Amid 140th Trading Volume Rank as Analysts Weigh Diagnostic Sector Growth and Competitive Risks - AInvest
Meal Replacement Market Is Booming Worldwide 2025-2032 | Abbott - openPR.com
Paul MacDonald's Top Picks: Stryker, Abbott Labs & Elevance Health - BNN Bloomberg
Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche - Yahoo Finance
0.14%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):